<DOC>
	<DOCNO>NCT00054717</DOCNO>
	<brief_summary>Demonstrate safety efficacy Tipranavir/Ritonavir versus active treatment regimen highly treatment experience Human Immunodeficiency virus 1 ( HIV-1 ) infect patient .</brief_summary>
	<brief_title>Randomized Evaluation Strategic Intervention Multidrug Resistant Patients With Tipranavir ( RESIST )</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Tipranavir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Patients meet follow criterion eligible participation th study : 1 . Human Immunodeficiency virus 1 ( HIV1 ) infect male female &gt; =18 year age . 2 . Screening genotypic resistance report indicate follow : least one primary protease Inhibitor ( PI ) mutation follow site : 30N , 46I/L , 48V , 50V , 82A/F/L/T , 84V 90M , two protease mutation codon 33 , 82 , 84 , 90 . 3 . At least 3 consecutive month experience take antiretrovirals ( ARVs ) class nucleoside reverse transcriptase inhibitor ( NRTI ( ) ) , nonnucleoside reverse transcriptase inhibitor ( NNRTI ( ) ) , protease inhibitor ( PIs ) point treatment history , least 2 protease inhibitor ( PI ) base regimen , one must current regimen , current protease inhibitor ( PI ) base antiretroviral ( ARV ) medication regimen least 3 month prior randomization . 4 . Human Immunodeficiency Virus 1 ( HIV1 ) viral load &gt; =1,000 copies/mL screening . Exclusion criterion : Patients follow criterion exclude participation study : 1 . Antiretroviral ( ARV ) medication na√Øve . 2 . Patients recent drug holiday , define antiretroviral ( ARV ) medication least 7 consecutive day within last 3 month . 3. alanine aminotransferase ( ALT ) &gt; =3.0x upper limit normal ( ULN ) aspartate aminotransferase ( AST ) &gt; =2.5x upper limit normal ( ULN ) ( &gt; =Division AIDS ( DAIDS ) Grade 1 ) either screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>